Atrixone-SB 375mg Injection
Marketer
Atlantis Formulations Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Atrixone-SB 375mg Injection
Combiflox-375 injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; prematurely halting treatment compromises its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand urgent medical attention. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor treatment response.
Uses of Atrixone-SB 375mg Injection
Infections caused by bacteria
Major Benefits of Atrixone-SB 375mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Atrixone-SB 375mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Atrixone-SB 375mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Atrixone-SB 375mg Injection works:
Ceftriaxone and sulbactam, combined as Atrixone-SB 375mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Atrixone-SB 375mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Atrixone-SB, 375mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; the available data from human trials, however, remains insufficient.
Breast feedingCAUTION
Administering Atrixone-SB 375mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Atrixone-SB 375mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Atrixone-SB 375mg Injection administration to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Atrixone-SB 375mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Atrixone-SB 375mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Atrixone-SB 375mg Injection :
Omit a scheduled Atrixone-SB 375mg Injection? Seek medical advice immediately.
Facts to Know About Atrixone-SB 375mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
3,018 People bought this recently